| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.093 | 0.005 |